8-K current report · filed Nov 13, 2026

AVITA Medical, Inc. (RCEL) 8-K Current Report: November 13, 2026

Item 7.01RCEL overview

Short answer

AVITA Medical, Inc. (RCEL) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 7.01 (Regulation FD Disclosure). Perceptive received 119,375 shares after cashless exercise of a warrant covering 150,000 shares.

AVITA Medical, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Perceptive received 119,375 shares after cashless exercise of a warrant covering 150,000 shares
  • Company withheld 30,625 shares for the Perceptive Warrant exercise price, limiting net dilution
  • OrbiMed received 148,158 shares after cashless exercise of a warrant covering 409,661 shares
  • Company withheld 261,503 shares for the OrbiMed Warrant exercise price, reducing potential dilution
  • Combined net issuance of 267,533 shares increases share count and reflects lender warrant monetization after financing activity

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other AVITA Medical, Inc. 8-K filings

Get the next RCEL 8-K as it lands

Follow RCEL for push alerts, or ask the research agent what this filing means.